GSK plc Director and Officer Stock Transactions - April 2026
This Form 6-K filing by GSK plc reports two separate stock transactions by company insiders in April 2026. Independent Non-Executive Director Wendy Becker purchased 4,000 ordinary shares at Β£19.6291 per share on April 29, 2026, on the London Stock Exchange. Separately, Chief People Officer Diana Conrad acquired 12.874 American Depositary Shares (ADS) at $54.5854 per share on April 27, 2026, through the GSK pension plan on the New York Stock Exchange. Both transactions represent initial notifications under securities regulations requiring disclosure of transactions by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them. The filing demonstrates compliance with disclosure requirements for insider trading activities, showing both executives increasing their ownership positions in the company through different types of securities transactions.